December 2020 Vol 11, No 12
Proceedings from key sessions from an AONN+ conference are presented in this CEU activity.
Immune checkpoint inhibitors (ICIs) have become a mainstay in the treatment of a variety of malignancies and are well-known as effective cancer therapies.
Working to alleviate lung cancer stigma helps patients to receive quality cancer care without the added burden of self-inflicted distress. Here’s how.
Do you recognize the barriers to care that women of racial minorities face? There may be more than you realize.
An essential primer on this rare form of breast cancer and the implications for the Navigator.
Chimeric antigen receptor (CAR) T-cell (CAR-T for short) products have the power and the potential to cure, according to Kathleen McDermott, RN, BSN, OCN, BMTCN, from Dana-Farber Cancer Institute in Boston.
Heeding a black box warning, the FDA’s most severe warning label, could mean the difference between life and death for a patient with cancer, according to Mary Jo Sarver, ARNP, AOCN, CRNI, VA-BC, LNC.
Telehealth is a valuable tool for delivering early palliative care to patients with cancer, especially for particularly vulnerable populations such as those with advanced disease.
Investing in a dedicated lay staff to facilitate admissions and discharges across care settings can lead to meaningful improvements in healthcare utilization and quality, and in the overall patient experience, according to results from a pilot program presented by Mark Liu, MHA, at the 2020 ASCO Quality Care Symposium.
The majority of patients with cancer pain need opioids. But in the midst of an ongoing opioid crisis in the United States, how do providers safely prescribe them to their patients? According to Jeannine Brant, PhD, APRN, AOCN, FAAN, this requires a safe and balanced approach to pain and symptom management.
The higher the financial distress experienced by a patient with cancer, the lower their health-related quality of life.
Results 1 - 14 of 14